These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 25673182

  • 21. Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
    Ouyang Y, Gao P, Zhu B, Chen X, Lin F, Wang X, Wei J, Zhang H.
    Mol Med Rep; 2015 Feb; 11(2):1435-41. PubMed ID: 25351256
    [Abstract] [Full Text] [Related]

  • 22. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Cancer Res; 2001 Oct 15; 61(20):7544-51. PubMed ID: 11606392
    [Abstract] [Full Text] [Related]

  • 23. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 24. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
    Meng D, Yang S, Wan X, Zhang Y, Huang W, Zhao P, Li T, Wang L, Huang Y, Li T, Li Y.
    Int J Biochem Cell Biol; 2016 Apr 15; 73():30-40. PubMed ID: 26827675
    [Abstract] [Full Text] [Related]

  • 25. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
    Sikand K, Slaibi JE, Singh R, Slane SD, Shukla GC.
    Int J Cancer; 2011 Aug 15; 129(4):810-9. PubMed ID: 21710544
    [Abstract] [Full Text] [Related]

  • 26. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J.
    Prostate; 2015 Aug 01; 75(11):1187-96. PubMed ID: 25894097
    [Abstract] [Full Text] [Related]

  • 27. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
    Ebron JS, Shukla GC.
    Prostate; 2016 Jun 01; 76(9):834-44. PubMed ID: 26988939
    [Abstract] [Full Text] [Related]

  • 28. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M, Takeuchi A, Song Y, Yokomizo A, Kashiwagi E, Uchiumi T, Kuroiwa K, Tatsugami K, Fujimoto N, Oda Y, Naito S.
    Endocr Relat Cancer; 2011 Aug 01; 18(4):505-17. PubMed ID: 21652770
    [Abstract] [Full Text] [Related]

  • 29. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
    Zhang HN, Yu CX, Zhang PJ, Chen WW, Jiang AL, Kong F, Deng JT, Zhang JY, Young CY.
    Acta Pharmacol Sin; 2007 Mar 01; 28(3):423-30. PubMed ID: 17303007
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 01; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 31. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K, Kawada M, Ohba S, Takamoto K, Ishizuka M.
    Mol Cell Endocrinol; 2004 Feb 12; 214(1-2):175-87. PubMed ID: 15062556
    [Abstract] [Full Text] [Related]

  • 32. Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.
    Bennett NC, Hooper JD, Johnson DW, Gobe GC.
    Prostate; 2014 May 12; 74(5):478-87. PubMed ID: 24375805
    [Abstract] [Full Text] [Related]

  • 33. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.
    Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538
    [Abstract] [Full Text] [Related]

  • 34. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A, Sallami S, Céraline J, Oueslati R.
    Cell Biol Int; 2013 May 01; 37(5):464-70. PubMed ID: 23418075
    [Abstract] [Full Text] [Related]

  • 35. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L.
    Oncogene; 2006 Nov 16; 25(54):7212-23. PubMed ID: 16732317
    [Abstract] [Full Text] [Related]

  • 36. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W, Keener AL, Jing Y, Cai L, Ai J, Zhang J, Fisher AL, Fu G, Wang Z.
    Prostate; 2015 Jun 15; 75(9):976-87. PubMed ID: 25808853
    [Abstract] [Full Text] [Related]

  • 37. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
    Li X, Wan X, Chen H, Yang S, Liu Y, Mo W, Meng D, Du W, Huang Y, Wu H, Wang J, Li T, Li Y.
    Clin Cancer Res; 2014 May 01; 20(9):2312-25. PubMed ID: 24610824
    [Abstract] [Full Text] [Related]

  • 38. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD, Lambert JR, Nordeen SK.
    Mol Cancer Res; 2010 Dec 01; 8(12):1643-55. PubMed ID: 21047772
    [Abstract] [Full Text] [Related]

  • 39. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 40. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    Hååg P, Bektic J, Bartsch G, Klocker H, Eder IE.
    J Steroid Biochem Mol Biol; 2005 Aug 01; 96(3-4):251-8. PubMed ID: 15982869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.